RxDoctor Payments Data

Jason Flassing

Physician Assistant · Greer, SCNPI 1912145970

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $18,975 of the $24,748 with a category attached, or 76.7%. AbbVie accounts for 85.4% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2023 at $10,760 and has fallen 94.3% since, to $609 in 2025. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,748in general payments, 2019–2025

Across 360 payments — averaging $68.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$21K
  • Takeda Pharmaceuticals U.S.A., Inc.$895
  • Otsuka America Pharmaceutical, Inc.$407
  • Supernus Pharmaceuticals, Inc.$364
  • Vanda Pharmaceuticals Inc.$295
  • Sunovion Pharmaceuticals Inc.$291
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$18,97577%
  • Travel & lodging$9574%
  • Food & beverage$4,76819%
  • Education$470%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,748 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$16,301
ConcertaMethylphenidate Hcl11$7,994
Lurasidone Hcl20$4,327
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine134$4,068
Modafinil14$3,798
Fluvoxamine Maleate ErFluvoxamine Maleate12$3,740
Desvenlafaxine Succinate ErDesvenlafaxine Succinate95$2,174
Clonazepam318$2,052
Eszopiclone43$1,967
Alprazolam235$1,906
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine29$1,904
Duloxetine Hcl109$1,786
Aripiprazole63$1,428
Bupropion XlBupropion Hcl84$1,428
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl20$1,225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$21,141$16,30111 claims
Johnson & JohnsonConcerta$87$7,99411 claims
Almatica Pharma LLCSertraline Hcl$42$20265 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Greer

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →